Christine Deuschel Cornioley
Director/Board Member at Biocartis SA
Profile
Christine Deuschel Cornioley is currently a Non-Executive Director at Biocartis SA since 2012.
Previously, she held positions such as Chief Executive Officer at Athelas SA, Non-Executive Director at Biocartis Group NV, Vice President-Portfolio & Project Management at Debiopharm International SA from 1995 to 2018, and Chief Scientific Officer at Anteis SA. She has also worked as a Faculty Member at the University of Bern.
Dr. Cornioley obtained a doctorate degree from the University of Fribourg in 1987 and holds an MBA from the Swiss Federal Institute of Technology, the University of Lausanne, and École des Hautes Études Commerciales de Paris.
Christine Deuschel Cornioley active positions
Companies | Position | Start |
---|---|---|
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Director/Board Member | - |
Former positions of Christine Deuschel Cornioley
Companies | Position | End |
---|---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Corporate Officer/Principal | 2017-12-31 |
BIOCARTIS GROUP NV | Director/Board Member | - |
Athelas SA | Chief Executive Officer | - |
Anteis SA
Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Chief Tech/Sci/R&D Officer | - |
University of Bern | Corporate Officer/Principal | - |
Training of Christine Deuschel Cornioley
University of Fribourg | Doctorate Degree |
Swiss Federal Institute of Technology | Masters Business Admin |
École des Hautes Études Commerciales de Paris | Masters Business Admin |
University of Lausanne | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BIOCARTIS GROUP NV | Health Technology |
Private companies | 4 |
---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
Anteis SA
Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Health Technology |
Athelas SA | Commercial Services |
- Stock Market
- Insiders
- Christine Deuschel Cornioley